Celiac.com Sponsor (A1):


Join eNewsletter


Celiac.com Sponsor (A1-m):



Join eNewsletter
  • Join Our Community!

    Ask us a question in our celiac / gluten-free forum.

  • Scott Adams

    Report Details the Impact of Covid-19 on Global Celiac Disease Drug Market

    Scott Adams
    0
    Reviewed and edited by a celiac disease expert.

      New reports assess the effects of Covid-19 on the global cealic disease drug market.


    Image: CC BY 2.0--e-MagineArt.com
    Caption: Image: CC BY 2.0--e-MagineArt.com

    Celiac.com 10/08/2020 - InForGrowth has released its latest research report on the current market for celiac disease drugs, along with development trends and forecasts through 2026. The 2020 Celiac Disease Drug Market Report's analyses include: the macroeconomic factors influencing the growth of the Celiac Disease Drug market; key trends shaping market growth; regions growth opportunities; strategies of key market players.

    The report seeks to assess the size of the current and future celiac disease drug market by analyzing historical data and future projections. It offers an overviews of market segments, including product types, applications, companies, and regions. 



    Celiac.com Sponsor (A12):






    Celiac.com Sponsor (A12-m):




    Moreover, the report includes a timely analysis on the impact of the COVID-19 pandemic on the Celiac Disease Drug market.  Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 180+ countries around the globe with the World Health Organization declaring it a public health emergency. 

    The COVID-19 pandemic will significantly affect the Celiac Disease Drug market in 2020 and beyond. The report assesses the impact of COVID-19 on the global economy, and on celiac drug markets, by analyzing: the impact of Covid-19 on global celiac drug production and demand; potential disturbances in the supply chain and market; and potential financial harm to firms and financial markets.

    Also included in the report are detailed analyses of each segment of the celiac disease drug market, based on product type, application, region, and major market players, including F. Hoffmann-La Roche, Johnson & Johnson, Merck, Pfizer, ADMA Biologics, Amgen, Anthera Pharmaceuticals, Bayer, Biogen, BioLineRx, Biotest, Bristol-Myers Squibb, Celgene, Takeda Pharmaceutical, Novartis, LFB Group, and Kedrion Biopharma.

    Read more at Scientect.com

    Get Exclusive Sample Report on Celiac Disease Drug Market here, and get the sample ToC on the CORONA Virus/COVID19 impact here.

    Edited by Scott Adams

    0

    User Feedback

    Recommended Comments

    There are no comments to display.



    Join the conversation

    You are posting as a guest. If you have an account, sign in now to post with your account.
    Note: Your post will require moderator approval before it will be visible.

    Guest
    Add a comment...

    ×   Pasted as rich text.   Restore formatting

      Only 75 emoji are allowed.

    ×   Your link has been automatically embedded.   Display as a link instead

    ×   Your previous content has been restored.   Clear editor

    ×   You cannot paste images directly. Upload or insert images from URL.


  • About Me

    Scott Adams was diagnosed with celiac disease in 1994, and, due to the nearly total lack of information available at that time, was forced to become an expert on the disease in order to recover. In 1995 he launched the site that later became Celiac.com to help as many people as possible with celiac disease get diagnosed so they can begin to live happy, healthy gluten-free lives.  He is co-author of the book Cereal Killers, and founder and publisher of the (formerly paper) newsletter Journal of Gluten Sensitivity. In 1998 he founded The Gluten-Free Mall which he sold in 2014. Celiac.com does not sell any products, and is 100% advertiser supported.


  • Celiac.com Sponsor (A17):
    Celiac.com Sponsor (A17):





    Celiac.com Sponsors (A17-m):




  • Related Articles

    Jefferson Adams
    Celiac.com 08/12/2017 - The latest research report from HTF Market Intelligence Consulting is titled "Global Celiac Disease Drugs Market 2017-2021." The report offers detailed information and analysis of the competitive market landscape, forecast and strategies.
    The report covers geographic analysis that includes regions like Americas, APAC, EMEA, along with important players, including F. Hoffmann-La Roche, Johnson & Johnson, Merck, and Pfizer. It provides information, market insights, future trends and growth prospects for forecast period of 2017-2021.
    The report presents a detailed picture of the market by way of study, synthesis, and summation...

    Jefferson Adams
    Celiac.com 03/30/2018 - The latest Gluten-Free Food Market Report offers a comprehensive global market evaluation, including enabling technologies, key trends, market drivers, challenges, standardization, regulatory landscape, opportunities, future road map, value chain, ecosystem player profiles and strategies. The report also includes global gluten-free investment forecasts from 2017 to 2022.
    The report covers top gluten-free manufacturers, including General Mills, Hain Celestial Group, Dr. Schar, Freedom Foods, Gruma, Kellogg, Kraft Heinz, Doves Farm, Amy’s Kitchen, Blue Diamond Growers, Enjoy Life Foods, Boulder Brands, and Bob’s Red Mill.

    Daniel Cojanu
    Celiac.com 01/25/2020 - Depending on what source you read, there may be as many as 6.5 million celiac patients in the U.S.  With these numbers, I have long believed that we really need to either find a cure or an effective way to manage this disease.  I, like many others, have been wondering if a "magic pill" would ever be produced so I could escape from the dry, terrible tasting, overpriced gluten-free food.  
    Thus, when I read an article about some research being done on celiac disease, I contacted the company conducting the clinical trials so I could be placed on their mailing list and hear about the results as soon as possible.  At the time, I ...

    Scott Adams
    Celiac.com 09/29/2020 - Currently, the only medically accepted treatment for celiac disease is a completely gluten-free diet (GFD), which can be both expensive and challenging to maintain. One promising celiac treatment currently in development is larazotide acetate (AT-1001), an anti-zonulin, designed to regulate gut permeability in people with celiac disease. 
    A team of researchers recently conducted a systematic review and meta-analysis of data from all randomized controlled trials (RCTs) assessing the effectiveness and safety of larazotide acetate in celiac patients. 
    The research team included Ahmed Abu-Zaid, Noor Tariq Alhaddab, R...